Skip to main content

PET/CT-Based Dose Planning in Radiation Therapy

  • Chapter
Diseases of the Abdomen and Pelvis 2014–2017

Abstract

Approximately 50% of cancer patients are estimated to receive radiation therapy as part of their total treatment regimen. External-beam treatment methods most commonly used at the Department of Radiation Oncology at Copenhagen University Hospital include 3D conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), intensity-modulated arc therapy (IMAT), and stereotactic radiation therapy (SRT). Radiation therapy can either cure patients of malignant disease or palliate symptoms caused by malignant disease. Radiation therapy is an inexpensive treatment method compared with, for example, surgery, chemotherapy, and immunotherapy [1]. One of the most pronounced disadvantages of radiation therapy is the acute side effects in normal tissue, e.g., mucous membranes occurring during and after the treatment. Correctly identifying and including all tumor cells in the target volume and avoiding as much normal tissue as possible is the challenge of curative radiation therapy, especially when the new treatment methods, such as 3D-CRT, IMRT, IMAT, and SRT, are used.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ringborg U, Bergqvist D, Brorsson B et al (2003) The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001—summary and conclusions. Acta Oncol 42:357–365.

    Article  PubMed  Google Scholar 

  2. Loft A, Berthelsen Kiil A, Roed H et al (2007) The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106:29–34.

    Article  PubMed  Google Scholar 

  3. Adriaensen M, Schijf L, de Haas M et al (2008) Six synchronous primary neoplasms detected by FDG-PET/CT. Eur J Nucl Med Mol Imaging 35:1931.

    Article  PubMed  Google Scholar 

  4. Ishimori T, Patel P, Wahl R (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46:752–757.

    PubMed  Google Scholar 

  5. MacManus M, Nestle U, Rosenzweig KE et al (2009) Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiat Oncol 91:85–94.

    Article  Google Scholar 

  6. Berthelsen AK, Dobbs J, Kjellén E et al (2007) What’s new in target volume definition for radiologists in ICRU Report 71? How can the ICRU volume definitions be integrated in clinical practice? Cancer Imaging 7:104–116.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Hutchings M, Loft A, Hansen M et al (2007) Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 78:206–212.

    Article  PubMed  Google Scholar 

  8. Caldwell CB, Mah K, Skinner M, Danjoux CE (2003) Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys 55:1381–1393.

    Article  PubMed  Google Scholar 

  9. Caldwell CB, Mah K, Ung YC et al (2001) Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51:923–931.

    Article  CAS  PubMed  Google Scholar 

  10. Leong T, Everitt C, Yuen K et al (2006) A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78:254–261.

    Article  PubMed  Google Scholar 

  11. Souvatzoglou M, Grosu AL, Röper B et al (2007) Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging 34:1566–1575.

    Article  CAS  PubMed  Google Scholar 

  12. Rajendran JG, Schwartz DL, O’Sullivan J et al (2006) Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12:5435–5441.

    Article  CAS  PubMed  Google Scholar 

  13. Grosu AL, Souvatzoglou M, Röper B et al (2007) Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69:541–551.

    Article  CAS  PubMed  Google Scholar 

  14. Grégoire V, Haustermans k, Geets X et al (2007) PET-based treatment planning in radiotherapy: a new standard? J Nucl Med 48(1suppl):68–77.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Loft, A., Berthelsen, A.K. (2014). PET/CT-Based Dose Planning in Radiation Therapy. In: Hodler, J., von Schulthess, G.K., Kubik-Huch, R.A., Zollikofer, C.L. (eds) Diseases of the Abdomen and Pelvis 2014–2017. Springer, Milano. https://doi.org/10.1007/978-88-470-5659-6_33

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5659-6_33

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5658-9

  • Online ISBN: 978-88-470-5659-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics